In summary, lncRNAs are pivotal regulators of glucose metabolism in cancer, exerting their influence through direct interactions with transcription factors such as MYC and HIF1α, thereby modulating the expression of key glycolytic enzymes and sustaining tumor metabolic reprogramming. This evidence concerns the gene MYC and cancer.